Vimarsana
Biggest News Aggregation in the World

Page 20 - Twist Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Twist Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Twist Bioscience Today - Breaking & Trending Today

Analysts Set Twist Bioscience Co. (NASDAQ:TWST) Price Target at $28.43 - Vimarsana News

Analysts Set Twist Bioscience Co. (NASDAQ:TWST) Price Target at $28.43

Shares of Twist Bioscience Co. (NASDAQ:TWST – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the seven analysts that are presently covering the firm, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The average […]

Despite Twist Bioscience's Pullback, Insiders Still Gained US$49k - Vimarsana News

Despite Twist Bioscience's Pullback, Insiders Still Gained US$49k

Insiders who purchased Twist Bioscience Corporation ( NASDAQ:TWST ) shares in the past 12 months are unlikely to be...

Source: yahoo.com
Twist Bioscience (TWST) Stock: A Hidden Value Trap? Unpacking the Risks and Rewards - Vimarsana News

Twist Bioscience (TWST) Stock: A Hidden Value Trap? Unpacking the Risks and Rewards

An in-depth analysis of Twist Bioscience's financial health and potential as an investment

Source: yahoo.com
Twist Bioscience Enters into Antibody Discovery and Licensing Option Agreement with Bayer of up to $188 Million - Vimarsana News

Twist Bioscience Enters into Antibody Discovery and Licensing Option Agreement with Bayer of up to $188 Million

Twist Bioscience Corporation , a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced an antibody discovery, option and...

Bayer to partner with Twist Bioscience to accelerate drug discovery - Vimarsana News

Bayer to partner with Twist Bioscience to accelerate drug discovery

Collaboration gives Bayer access to Twist Bioscience’s pool of phage display libraries / Twist Bioscience eligible to receive up to USD 188 million in clinical and commercial milestone payments plus royalties

Source: bayer.com